Zydus Lifesciences zooms as its arm inks definitive pact to acquire outstanding shares of Assertio

Zydus Lifesciences zooms as its arm inks definitive pact to acquire outstanding shares of Assertio

Mumbai, May 14 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 983.00, up by 44.05 points or 4.69% from its previous closing of Rs. 938.95 on the BSE. The scrip opened at Rs. 965.20 and has touched a high and low of Rs. 984.20 and Rs. 960.15 respectively. So far 93551 shares were traded … Read more

Zydus Lifesciences gains on getting USFDA’s approval for ‘Dapagliflozin Tablets’

Zydus Lifesciences zooms as its arm inks definitive pact to acquire outstanding shares of Assertio

Mumbai, April 8 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 884.35, up by 10.70 points or 1.22% from its previous closing of Rs. 873.65 on the BSE. The scrip opened at Rs. 910.80 and has touched a high and low of Rs. 910.80 and Rs. 879.90 respectively. So far 29876 shares were traded … Read more

Zydus Lifesciences climbs on planning to launch Semaglutide injection in India

Zydus Lifesciences zooms as its arm inks definitive pact to acquire outstanding shares of Assertio

Mumbai, February 26 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 941.50, up by 22.10 points or 2.40% from its previous closing of Rs. 919.40 on the BSE. The scrip opened at Rs. 937.90 and has touched a high and low of Rs. 947.70 and Rs. 922.20 respectively. So far 21972 shares were traded … Read more

Zydus Lifesciences moves up on getting USFDA’s final approval for Ammonium Lactate Cream

Zydus Lifesciences zooms as its arm inks definitive pact to acquire outstanding shares of Assertio

Mumbai, February 16 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 910.65, up by 5.80 points or 0.64% from its previous closing of Rs. 904.85 on the BSE. The scrip opened at Rs. 904.80 and has touched a high and low of Rs. 916.00 and Rs. 904.25 respectively. So far 3360 shares were traded … Read more

Zydus Lifesciences Rises as Subsidiary Launches Generic Veterinary Drug in US

Zydus Lifesciences

Mumbai, September 16 (Patrika English News). Shares of Zydus Lifesciences edged higher on Tuesday after its step-down wholly owned subsidiary, ZyVet Animal Health, launched the first FDA-approved generic of phenylpropanolamine hydrochloride tablets in the United States. The stock opened at ₹1,037.35 on the BSE and touched a high of ₹1,043.35 before trading at ₹1,038.35, up … Read more

BREAKING NEWS:
“Prateek Yadav dreams of owning a ₹5 crore ‘Blue Bolt'” Kia Sonet’s Second Generation: Enhanced Safety and Features! Will WhatsApp require a subscription? Discover the truth!